Announcements Trials
Browse Landscape

Phase

Phase 2 198Phase 3 83Phase 1 40Phase 1/2 39Phase NA 18Phase 4 18Phase 2/3 15Phase EARLY_PHASE1 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 4CNS 3Other hematologic neoplasm 2Genitourinary 1

Conditions

Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Mantle-Cell 1Leukemia, Large Granular Lymphocytic 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 10fludarabine 5Etoposide 5venetoclax 3Stem Cell Transplantation 3Sirolimus 3Exercise 3Cytarabine 3pembrolizumab 2Vincristine 2Transplantation 2Peripheral Blood Stem Cell Transplantation 2Methotrexate 2Magnetic Resonance Spectroscopy 2Influenza Vaccines 2Immunotherapy, Adoptive 2Ifosfamide 2Idarubicin 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Doxorubicin 2Dexamethasone 2Counseling 2Cord Blood Stem Cell Transplantation 2Biopsy 2Azacitidine 2siltuximab 1ruxolitinib 1pirtobrutinib 1nilotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Methotrexate × Other hematologic neoplasm × Clear all
NCT03719105 2025-08-08

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

New York Medical College

Phase EARLY_PHASE1 Recruiting
40 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, T-Cell, Peripheral, Leukemia, Large Granular Lymphocytic

NCT01184885 2025-05-04

A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy

Thomas Jefferson University

Phase EARLY_PHASE1 Completed
7 enrolled 8 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Recurrence, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡